D-1188-2018 Class III Terminated
FDA drug recall D-1188-2018 was initiated by United Therapeutics Corp. on Aug 14, 2018 and is designated Class III. Reason for recall: Defective Delivery System: Water ingress through the lower water cup sensor of the device. The recall status is terminated (terminated Oct 30, 2019). Affected quantity: 2801 devices.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 19, 2018
- Initiation Date
- Aug 14, 2018
- Termination Date
- Oct 30, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2801 devices
Product description
Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Only. Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709
Reason for recall
Defective Delivery System: Water ingress through the lower water cup sensor of the device.
Distribution pattern
IL, PA
Code information
Lot number a) 2101503, 2101507, 2101523, 2101532, 2101533, EXP 07/31/2019; 2101557, EXP 11/30/2019 b) Lot # 2101504, EXP 4/24/2021; 2101509, 2101522, EXP 5/8/2021; 2101531, EXP 5/15/2021; 2101534, EXP 6/10/2021; 2101543, EXP 6/14/2021; 2101558, EXP 7/26/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1188-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026